Asthma and COPD Drugs Market to Surge to USD 50.42 Billion by 2033

New York, Friday, 21 November 2025.
The global market for asthma and COPD drugs is projected to expand from USD 33.16 billion in 2025 to USD 50.42 billion by 2033, driven by increasing respiratory disease prevalence and combination therapy adoption.